Cervicovaginal cytology in patients undergoing pelvic radiotherapy using the Focalpoint system: results from the RODEO study

Table 1 Number and percentage of cases according to cytology result and previous radiotherapy status read manually

Cytology result	No previous radiotherapy	Previous radiotherapy	PR	95% CI (PR)
Cytology result	N (%)	N (%)	PR	95% CI (PR)
Negative	8,589 (95.8)	327 (86.5)	0.9	0.87 – 0.94
ASCUS	72 (0.8)	6 (1.6)	2.0	0.9 – 4.5
ASC-H + AGC	83 (0.9)	17 (4.5)	5.0	2.9 – 8.1
LSIL	107 (1.2)	11 (2.9)	2.4	1.3 – 4.5
HSIL or worse	116 (1.3)	17 (4.5)	3.5	2.1 – 5.7

PR = prevalence ratio (ratio of cytology abnormalities between the groups who did or did not receive previous radiotherapy).
95% CI = 95% confidence interval.

ISSN: 1746-1596